Schechter Investment Advisors’s PepperLime Health Acquisition Corporation Unit PEPLU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-38,110
Closed -$386K 917
2022
Q4
$386K Sell
38,110
-1,650
-4% -$16.5K 0.04% 565
2022
Q3
$396K Sell
39,760
-169
-0.4% -$1.69K 0.04% 583
2022
Q2
$393K Buy
39,929
+2,400
+6% +$24K 0.04% 609
2022
Q1
$377K Buy
37,529
+954
+3% +$9.7K 0.04% 622
2021
Q4
$358K Buy
+36,575
New +$365K 0.03% 621

Other funds holding PEPLU

Schechter Investment Advisors's PEPLU Position: Q1 2023 in Review

Schechter Investment Advisors sold out of PepperLime Health Acquisition Corporation Unit (PEPLU) in Q1 2023, closing a stake of 38,110 shares — an estimated $386K sold.

Schechter Investment Advisors first reported a position in PEPLU in Q4 2021 and held it in 5 quarters. The position peaked at $396K in Q3 2022. 1 fund tracked by Wall St. Rank holds PEPLU as of Q1 2023.

  • Schechter Investment Advisors reported no remaining PepperLime Health Acquisition Corporation Unit position as of Q1 2023 after selling out during the quarter.
  • Schechter Investment Advisors sold 38,110 PepperLime Health Acquisition Corporation Unit shares in Q1 2023, an estimated $386K.
  • Schechter Investment Advisors first reported a position in PepperLime Health Acquisition Corporation Unit in Q4 2021 and held it in 5 quarters.
  • Schechter Investment Advisors's PepperLime Health Acquisition Corporation Unit position peaked at $396K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Unit as of Q1 2023.

Based on Schechter Investment Advisors's 13F filing for Q1 2023, filed 28 Apr 2023.